Fate of recombinant adeno-associated viral vector genomes during DNA double-strand break-induced gene targeting in human cells

Human Gene Therapy

Volumn 21, Issue 5, 2010, Pages 543-553

  Gellhaus, Katharina ^a,b   Cornu, Tatjana I ^a,b   Heilbronn, Regine ^a   Cathomen, Toni ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b EPIONTIS GMBH   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; ENHANCED GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; GENE EXPRESSION; GENE LOCUS; GENE TARGETING; GENETIC ENGINEERING; HUMAN; HUMAN CELL; TARGETED GENE REPAIR; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS RECOMBINANT;

CELL LINE; DEPENDOVIRUS; DNA BREAKS, DOUBLE-STRANDED; GENE TARGETING; GENETIC VECTORS; GENOME, VIRAL; GREEN FLUORESCENT PROTEINS; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC;

ADENO-ASSOCIATED VIRUS; MAMMALIA;

EID: 77951971881     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.167     Document Type: Article

References (52)

1. Alwin, S., Gere, M.B., Guhl, E., Effertz, K., Barbas, C.F., III, Segal, D.J., Weitzman, M.D., and Cathomen, T. (2005). Custom zinc-finger nucleases for use in human cells. Mol. Ther. 12, 610-617.
2. Bartlett, J.S., Wilcher, R., and Samulski, R.J. (2000). Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 74, 2777-2785.
3. Bell, P., Moscioni, A.D., McCarter, R.J., Wu, D., Gao, G., Hoang, A., Sanmiguel, J.C., Sun, X., Wivel, N.A., Raper, S.E., Furth, E.E., Batshaw, M.L., and Wilson, J.M. (2006). Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver. Mol. Ther. 14, 34-44.
4. Bohne, J., and Cathomen, T. (2008). Genotoxicity in gene therapy: An account of vector integration and designer nucleases. Curr. Opin. Mol. Ther. 10, 214-223.
5. Buning, H., Perabo, L., Coutelle, O., Quadt-Humme, S., and Hallek, M. (2008). Recent developments in adeno-associated virus vector technology. J. Gene Med. 10, 717-733.
6. Carroll, D. (2008). Progress and prospects: Zinc-finger nucleases as gene therapy agents. Gene Ther. 15, 1463-1468.
7. Cathomen, T. (2004). AAV vectors for gene correction. Curr. Opin. Mol. Ther. 6, 360-366.
8. Cathomen, T., and Joung, J.K. (2008). Zinc-finger nucleases: the next generation emerges. Mol. Ther. 16, 1200-1207.
9. Cervelli, T., Palacios, J.A., Zentilin, L., Mano, M., Schwartz, R.A., Weitzman, M.D., and Giacca, M. (2008). Processing of re-combinant AAV genomes occurs in specific nuclear structures that overlap with foci of DNA-damage-response proteins. J. Cell Sci. 121, 349-357.
10. Chamberlain, J.R., Deyle, D.R., Schwarze, U., Wang, P., Hirata, R.K., Li, Y., Byers, P.H., and Russell, D.W. (2008). Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta. Mol. Ther. 16, 187-193.
11. Choi, V.W., McCarty, D.M., and Samulski, R.J. (2006). Host cell DNA repair pathways in adeno-associated viral genome processing. J. Virol. 80, 10346-10356.
12. Choulika, A., Perrin, A., Dujon, B., and Nicolas, J.F. (1995). Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 1968-1973.
13. Cornu, T.I., and Cathomen, T. (2007). Targeted genome modifications using integrase-deficient lentiviral vectors. Mol. Ther. 15, 2107-2113.
14. Cornu, T.I., Thibodeau-Beganny, S., Guhl, E., Alwin, S., Eich-tinger, M., Joung, J.K., and Cathomen, T. (2008). DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger nucleases. Mol. Ther. 16, 352-358.
15. Cummins, J.M., Rago, C., Kohli, M., Kinzler, K.W., Lengauer, C., and Vogelstein, B. (2004). Tumour suppression: Disruption of HAUSP gene stabilizes p53. Nature 428, 1p following 486.
16. Donsante, A., Miller, D.G., Li, Y., Vogler, C., Brunt, E.M., Russell, D.W., and Sands, M.S. (2007). AAV vector integration sites in mouse hepatocellular carcinoma. Science 317, 477.
17. Duan, D., Yue, Y., and Engelhardt, J.F. (2003). Consequences of DNA-dependent protein kinase catalytic subunit deficiency on recombinant adeno-associated virus genome circularization and heterodimerization in muscle tissue. J. Virol. 77, 4751-4759.
18. Engelhardt, J.F. (2006). AAV hits the genomic bull's-eye. Nat. Biotechnol. 24, 949-950.
19. Fattah, F.J., Lichter, N.F., Fattah, K.R., Oh, S., and Hendrickson, E.A. (2008). Ku70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cells. Proc. Natl. Acad. Sci. U.S.A. 105, 8703-8708.
20. Fisher, K.J., Jooss, K., Alston, J., Yang, Y., Haecker, S.E., High, K., Pathak, R., Raper, S.E., and Wilson, J.M. (1997). Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3, 306-312.
21. Händel, E.M., Alwin, S., and Cathomen, T. (2009). Expanding or restricting the target site repertoire of zinc-finger nucleases: the inter-domain linker as a major determinant of target site selectivity. Mol. Ther. 17, 104-111.
22. Hendrie, P.C., and Russell, D.W. (2005). Gene targeting with viral vectors. Mol. Ther. 12, 9-17.
23. Hendrie, P.C., Hirata, R.K., and Russell, D.W. (2003). Chromosomal integration and homologous gene targeting by replication-incompetent vectors based on the autonomous par-vovirus minute virus of mice. J. Virol. 77, 13136-13145.
24. Hirata, R.K., and Russell, D.W. (2000). Design and packaging of adeno-associated virus gene targeting vectors. J. Virol. 74, 4612-4620.
25. Inagaki, K., Piao, C., Kotchey, N.M., Wu, X., and Nakai, H. (2008). Frequency and spectrum of genomic integration of recombinant adeno-associated virus serotype 8 vector in neonatal mouse liver. J. Virol. 82, 9513-9524.
26. Inoue, N., Hirata, R.K., and Russell, D.W. (1999). High-fidelity correction of mutations at multiple chromosomal positions by adeno-associated virus vectors. J. Virol. 73, 7376-7380.
27. Kohli, M., Rago, C., Lengauer, C., Kinzler, K.W., and Vogelstein, B. (2004). Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses. Nucleic Acids Res. 32, e3.
28. Liu, X., Yan, Z., Luo, M., Zak, R., Li, Z., Driskell, R.R., Huang, Y., Tran, N., and Engelhardt, J.F. (2004). Targeted correction of single-base-pair mutations with adeno-associated virus vectors under nonselective conditions. J. Virol. 78, 4165-4175.
29. Lombardo, A., Genovese, P., Beausejour, C.M., Colleoni, S., Lee, Y.L., Kim, K.A., Ando, D., Urnov, F.D., Galli, C., Gregory, P.D., Holmes, M.C., and Naldini, L. (2007). Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25, 1298-1306.
30. Maeder, M.L., Thibodeau-Beganny, S., Osiak, A., Wright, D.A., Anthony, R.M., Eichtinger, M., Jiang, T., Foley, J.E., Winfrey, R.J., Townsend, J.A., Unger-Wallace, E., Sander, J.D., Muller-Lerch, F., Fu, F., Pearlberg, J., Gobel, C., Dassie, J.P., Pruett-Miller, S.M., Porteus, M.H., Sgroi, D.C., Iafrate, A.J., Dobbs, D., McCray, P.B., Jr., Cathomen, T., Voytas, D.F., and Joung, J.K. (2008). Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol. Cell 31, 294-301.
31. Miller, D.G., Petek, L.M., and Russell, D.W. (2003). Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks. Mol. Cell. Biol. 23, 3550-3557.
32. Miller, D.G., Petek, L.M., and Russell, D.W. (2004). Adeno-as-sociated virus vectors integrate at chromosome breakage sites. Nat. Genet. 36, 767-773.
33. Miller, D.G., Trobridge, G.D., Petek, L.M., Jacobs, M.A., Kaul, R., and Russell, D.W. (2005). Large-scale analysis of adeno-associated virus vector integration sites in normal human cells. J. Virol. 79, 11434-11442.
34. Miller, D.G., Wang, P.R., Petek, L.M., Hirata, R.K., Sands, M.S., and Russell, D.W. (2006). Gene targeting in vivo by adeno-associated virus vectors. Nat. Biotechnol. 24, 1022-1026.
35. Nakai, H., Iwaki, Y., Kay, M.A., and Couto, L.B. (1999). Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J. Virol. 73, 5438-5447.
36. Nakai, H., Yant, S.R., Storm, T.A., Fuess, S., Meuse, L., and Kay, M.A. (2001). Extrachromosomal recombinant adeno-associ-ated virus vector genomes are primarily responsible for stable liver transduction in vivo. J. Virol. 75, 6969-6976.
37. Nakai, H., Montini, E., Fuess, S., Storm, T.A., Grompe, M., and Kay, M.A. (2003). AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat. Genet. 34, 297-302.
38. Nakai, H., Wu, X., Fuess, S., Storm, T.A., Munroe, D., Montini, E., Burgess, S.M., Grompe, M., and Kay, M.A. (2005). Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver. J. Virol. 79, 3606-3614.
39. Paques, F., and Duchateau, P. (2007). Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapy. Curr. Gene Ther. 7, 49-66.
40. Porteus, M.H., Cathomen, T., Weitzman, M.D., and Baltimore, D. (2003). Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks. Mol. Cell. Biol. 23, 3558-3565.
41. Rouet, P., Smih, F., and Jasin, M. (1994). Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 91, 6064-6068.
42. Russell, D.W., and Hirata, R.K. (1998). Human gene targeting by viral vectors. Nat. Genet. 18, 325-330.
43. Sanlioglu, S., Benson, P., and Engelhardt, J.F. (2000). Loss of ATM function enhances recombinant adeno-associated virus transduction and integration through pathways similar to UV irradiation. Virology 268, 68-78.
44. Song, S., Lu, Y., Choi, Y.K., Han, Y., Tang, Q., Zhao, G., Berns, K.I., and Flotte, T.R. (2004). DNA-dependent PK inhibits adeno-associated virus DNA integration. Proc. Natl. Acad. Sci. U.S.A. 101, 2112-2116.
45. Summerford, C., and Samulski, R.J. (1998). Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72, 1438-1445.
46. 5 integrin: A co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5, 78-82.
47. Urnov, F.D., Miller, J.C., Lee, Y.L., Beausejour, C.M., Rock, J.M., Augustus, S., Jamieson, A.C., Porteus, M.H., Gregory, P.D., and Holmes, M.C. (2005). Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435, 646-651.
48. Vasileva, A., and Jessberger, R. (2005). Precise hit: Adeno-associated virus in gene targeting. Nat. Rev. Microbiol. 3, 837-847.
49. Vasileva, A., Linden, R.M., and Jessberger, R. (2006). Homologous recombination is required for AAV-mediated gene targeting. Nucleic Acids Res. 34, 3345-3360.
50. Vasquez, K.M., Marburger, K., Intody, Z., and Wilson, J.H. (2001). Manipulating the mammalian genome by homologous recombination. Proc. Natl. Acad. Sci. U.S.A. 98, 8403-8410.
51. Yan, Z., Sun, X., and Engelhardt, J.F. (2009). Progress and prospects: Techniques for site-directed mutagenesis in animal models. Gene Ther. 16, 581-588.
52. Zentilin, L., Marcello, A., and Giacca, M. (2001). Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome. J. Virol. 75, 12279-12287.